Relative Value

There is not enough data to reliably calculate the relative value of PCA.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PCA Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0.5
Median 5Y
0.5
Industry
4.3
vs History
vs Industry
Median 3Y
12.6
Median 5Y
12
Industry
33.8
vs History
vs Industry
Median 3Y
-40.5
Median 5Y
-40.5
Industry
20.2
vs History
vs Industry
Median 3Y
-2.3
Median 5Y
-2.3
Industry
27.4
vs History
vs Industry
Median 3Y
15.3
Median 5Y
14.7
Industry
3
vs History
vs Industry
Median 3Y
0.8
Median 5Y
0.8
Industry
4.3
vs History
vs Industry
Median 3Y
2.1
Median 5Y
2.1
Industry
9.7
vs History
vs Industry
Median 3Y
-188.7
Median 5Y
-183.6
Industry
19.7
vs History
vs Industry
Median 3Y
-6.7
Median 5Y
-6.7
Industry
25.5
vs History
vs Industry
Median 3Y
-65.4
Median 5Y
-65.4
Industry
20.4
vs History
vs Industry
Median 3Y
-4
Median 5Y
-4
Industry
28.3
vs History
vs Industry
Median 3Y
0.7
Median 5Y
0.7
Industry
2.5

Multiples Across Competitors

PCA Competitors Multiples
Pcas SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
Pcas SA
PAR:PCA
109.9m EUR 0.5 12.5 -188.7 -6.7
US
PerkinElmer Inc
LSE:0KHE
1.1T USD 403.6 4 781.9 1 402.4 2 817.5
US
Thermo Fisher Scientific Inc
NYSE:TMO
232.8B USD 5.3 35.4 25.1 32.6
US
Danaher Corp
NYSE:DHR
168.3B USD 6.9 47.9 25.7 38.9
CH
Lonza Group AG
SIX:LONN
38.9B CHF 5.4 53.2 40.3 39.9
US
Agilent Technologies Inc
NYSE:A
42.2B USD 6.1 32.3 25 29.7
US
IQVIA Holdings Inc
NYSE:IQV
41.1B USD 2.6 32 15.3 23.1
CN
WuXi AppTec Co Ltd
SSE:603259
282.2B CNY 6.4 18.8 21.4 21.5
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW 8.4 29 16.9 22.5
US
Mettler-Toledo International Inc
NYSE:MTD
30.4B USD 7.7 36.3 26.1 29
FR
Sartorius Stedim Biotech SA
PAR:DIM
21B EUR 7 79.1 28.2 45.4
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
FR
Pcas SA
PAR:PCA
Average EV/EBITDA: 162.6
Negative Multiple: -188.7
N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
1 402.4
5%
280.5
US
Thermo Fisher Scientific Inc
NYSE:TMO
25.1
6%
4.2
US
Danaher Corp
NYSE:DHR
25.7
5%
5.1
CH
Lonza Group AG
SIX:LONN
40.3
18%
2.2
US
Agilent Technologies Inc
NYSE:A
25
13%
1.9
US
IQVIA Holdings Inc
NYSE:IQV
15.3
8%
1.9
CN
WuXi AppTec Co Ltd
SSE:603259
21.4
30%
0.7
KR
Samsung Biologics Co Ltd
KRX:207940
16.9
20%
0.8
US
Mettler-Toledo International Inc
NYSE:MTD
26.1
4%
6.5
FR
Sartorius Stedim Biotech SA
PAR:DIM
28.2
19%
1.5
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
FR
Pcas SA
PAR:PCA
Average EV/EBIT: 310
Negative Multiple: -6.7
N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
2 817.5
29%
97.2
US
Thermo Fisher Scientific Inc
NYSE:TMO
32.6
15%
2.2
US
Danaher Corp
NYSE:DHR
38.9
16%
2.4
CH
Lonza Group AG
SIX:LONN
39.9
22%
1.8
US
Agilent Technologies Inc
NYSE:A
29.7
23%
1.3
US
IQVIA Holdings Inc
NYSE:IQV
23.1
15%
1.5
CN
WuXi AppTec Co Ltd
SSE:603259
21.5
23%
0.9
KR
Samsung Biologics Co Ltd
KRX:207940
22.5
28%
0.8
US
Mettler-Toledo International Inc
NYSE:MTD
29
5%
5.8
FR
Sartorius Stedim Biotech SA
PAR:DIM
45.4
31%
1.5